Enlightenment Research, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Enlightenment Research, LLC

  • $0
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $286,985 - $362,160
500 New
500 $344,000
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $597,828 - $738,067
-1,100 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$574.03 - $680.96 $631,433 - $749,056
1,100 New
1,100 $666,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Enlightenment Research, LLC Portfolio

Follow Enlightenment Research, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Enlightenment Research, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email